At 5.8% CAGR, North America Cough Drops Market is Projected to be Worth US$ 910.14 Million by 2031, says Business Market Insights

According to Business Market Insights research, the North America cough drops market was valued at US$ 580.21 million in 2023 and is expected to reach US$ 910.14 million by 2031, registering a CAGR of 5.8% from 2023 to 2031. Adoption of innovative marketing strategies and increasing shift toward self-medication are among the critical factors attributed to driving the North America cough drops market growth.

With the rise of digital platforms, manufacturers use social media and online marketing campaigns to reach their target audiences effectively. Collaborating with health and wellness influences is considered as a constructive way to enhance credibility and visibility. Campaigns featuring influencers discussing the medical benefits of their cough drops can build consumer trust and boost sales. Brands can also focus on creating informative content that showcases product benefits and health topics, fostering brand loyalty by establishing themselves as trusted sources. In October 2023, HALLS partnered with Grammy-nominated Atlanta rapper Latto to refresh the motivational phrases on HALLS cough drop wrappers. Further, manufacturers can employ data analytics for advertising campaigns that resonate with specific demographics. By analyzing consumer behavior, companies tailor their messages to meet the needs of various segments, such as millennials, who seek natural ingredients in their medications. Moreover, advertising during peak respiratory illness seasons can significantly increase sales. For example, campaigns highlighting cough drops' effectiveness during flu season can attract more buyers. Thus, the adoption of innovative marketing strategies and data analytics tools are emerging as significant growth trends in the cough drops market.

On the contrary, the inability to provide long-term relief and availability of alternatives hampers the growth of North America cough drops market.

By product, the North America cough drops market is segmented into gluten free, sugar free, and others. The sugar free held 48.1% share of North America cough drops market share in 2023, amassing US$ 278.81 million. It is projected to garner US$ 446.66 million by 2031 to register 6.1% CAGR during 2023–2031.

By application, the North America cough drops market is bifurcated into adults and children. The adults held 80.4% share of North America cough drops market share in 2023, amassing US$ 466.59 million. It is projected to garner US$ 738.01 million by 2031 to register 5.9% CAGR during 2023–2031.

By distribution channel, the North America cough drops market is segmented into offline and online. The offline held 70.4% share of North America cough drops market share in 2023, amassing US$ 408.46 million. It is projected to garner US$ 623.65 million by 2031 to register 5.4% CAGR during 2023–2031.

Based on country, the North America cough drops market is categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 89.4% share of North America cough drops market in 2023. It was assessed at US$ 518.48 million in 2023 and is likely to hit US$ 818.28 million by 2031, registering a CAGR of 5.9% during 2023–2031.

Key players operating in the cough drops market are Bliss GVS Pharma Ltd, Cipla Ltd, Gepach International, GSK Plc, Mondelez International Inc, Reckitt Benckiser Group Plc, Ricola, Sanofi SA, The Procter & Gamble Co, and Thornton & Ross, among others.

• In September 2024: Cofsils, a brand by Cipla Health Ltd. specializing in sore throat relief, launched a new flavor: Cofsils Mulethi. This lozenge offers the soothing taste of Mulethi (Licorice) and provides relief from sore throat in just five minutes. Cofsils Mulethi joined the existing flavors, including Cofsils Fresh Mint, Cofsils Tulsi Pudina, and popular options like Cofsils Orange, Lemon Honey, and Ginger Lemon.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com